Western Oncolytics Ltd. Revenue and Competitors
Estimated Revenue & Valuation
- Western Oncolytics Ltd.'s estimated annual revenue is currently $1.6M per year.
- Western Oncolytics Ltd.'s estimated revenue per employee is $155,000
Employee Data
- Western Oncolytics Ltd. has 10 Employees.
- Western Oncolytics Ltd. grew their employee count by 0% last year.
Western Oncolytics Ltd.'s People
| Name | Title | Email/Phone |
|---|---|---|
1 | Technician | Reveal Email/Phone |
Western Oncolytics Ltd. Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $1.6M | 10 | 0% | N/A | N/A |
#2 | $4M | 26 | 13% | N/A | N/A |
#3 | $0.9M | 6 | -14% | N/A | N/A |
#4 | $1.1M | 7 | 0% | N/A | N/A |
#5 | $10.9M | 70 | 3% | N/A | N/A |
#6 | $0.7M | 9 | 29% | N/A | N/A |
#7 | $4M | 26 | -16% | N/A | N/A |
#8 | $1.7M | 11 | 22% | N/A | N/A |
#9 | $7.6M | 49 | 2% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is Western Oncolytics Ltd.?
Western Oncolytics was founded in 2014 to bring cutting-edge, next-generation oncolytic immunotherapies to cancer patients everywhere. Spun out of University of Pittsburgh's world-class oncolytic virus and immunotherapy research programs, our company is now advancing multiple therapeutic candidates towards the clinic and occupies over 18,000 square feet of lab space in our Pittsburgh headquarters. We are engineering an optimized vaccinia virus-based oncolytic platform which can be combined with multiple transgenes to create versatile and differentiated immunotherapies. Our development programs are designed to be safe, potent, and systemically deliverable to treat cancer patients across a variety of tumor types. In 2016, we formed a strategic partnership with Pfizer for our lead preclinical program, WO-12.
keywords:N/A
N/A
Total Funding
10
Number of Employees
$1.6M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Western Oncolytics Ltd. News
... the potency and selectivity of these EV inhibitors was limited, ... Oncolytics 23, 8295. https://doi.org/10.1016/j.omto.2021.08.015...
Oncolytic herpes simplex virus (oHSV) are promising OVs which have ... DNA Ladder, enzyme-linked immunosorbent assay and western blot assay.
Dr. Chaye most recently served as chief business officer for SillaJen, Inc., an oncolytic virus therapy company, and brings over 20 years of...
Other Companies in Pittsburgh
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $1.3M | 10 | -41% | N/A |
#2 | $0.9M | 10 | 0% | N/A |
#3 | $0.9M | 10 | -9% | N/A |
#4 | $0.9M | 10 | -17% | N/A |
#5 | $0.9M | 10 | 0% | N/A |